Improving the "quality of remission induction" therapy: a necessary step for increasing the cure rate in acute myelogenous leukemia.
Arlin
Z A
ZA
Feldman
E
E
Finger
L
L
Decter
J
J
Cook
P
P
Ahmed
T
T
Puccio
C
C
Chun
H
H
Mittelman
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012074:Remission Induction
D003561:Cytarabine